Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aurora Lorefice

Showing results (1-10 of 2) with videos related to

Pageof 1
Sort By:
JAMA Network Open|November 20, 2025
Nirsevimab Prophylaxis and Respiratory Syncytial Virus Hospitalizations Among InfantsEnrico Cocchi, Silvia Bloise, Aurora Lorefice, et al.
BMJ Paediatrics Open|October 14, 2025
Multicentre study on nirsevimab: Bayesian analysis reveals persisting risk for preterm infantsEnrico Cocchi, Silvia Bloise, Aurora Lorefice, et al.
Pageof 1

Showing results (1-10 of 2) with videos related to

Sort By:
Pageof 1
JAMA Network Open|November 20, 2025
Nirsevimab Prophylaxis and Respiratory Syncytial Virus Hospitalizations Among InfantsEnrico Cocchi, Silvia Bloise, Aurora Lorefice, et al.
BMJ Paediatrics Open|October 14, 2025
Multicentre study on nirsevimab: Bayesian analysis reveals persisting risk for preterm infantsEnrico Cocchi, Silvia Bloise, Aurora Lorefice, et al.
Pageof 1